These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38512072)

  • 1. ATP1A2-related epileptic encephalopathy and movement disorder: Clinical features of three novel patients.
    Córdoba NM; Lince-Rivera I; Gómez JLR; Rubboli G; De la Rosa SO
    Epileptic Disord; 2024 Jun; 26(3):332-340. PubMed ID: 38512072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early onset severe ATP1A2 epileptic encephalopathy: Clinical characteristics and underlying mutations.
    Moya-Mendez ME; Mueller DM; Pratt M; Bonner M; Elliott C; Hunanyan A; Kucera G; Bock C; Prange L; Jasien J; Keough K; Shashi V; McDonald M; Mikati MA
    Epilepsy Behav; 2021 Mar; 116():107732. PubMed ID: 33493807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FBXO28 causes developmental and epileptic encephalopathy with profound intellectual disability.
    Schneider AL; Myers CT; Muir AM; Calvert S; Basinger A; Perry MS; Rodan L; Helbig KL; Chambers C; Gorman KM; King MD; Donkervoort S; Soldatos A; Bönnemann CG; Spataro N; Gabau E; Arellano M; Cappuccio G; Brunetti-Pierri N; Rossignol E; Hamdan FF; Michaud JL; Balak C; Mefford HC; Scheffer IE
    Epilepsia; 2021 Jan; 62(1):e13-e21. PubMed ID: 33280099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP1A2- and ATP1A3-associated early profound epileptic encephalopathy and polymicrogyria.
    Vetro A; Nielsen HN; Holm R; Hevner RF; Parrini E; Powis Z; Møller RS; Bellan C; Simonati A; Lesca G; Helbig KL; Palmer EE; Mei D; Ballardini E; Van Haeringen A; Syrbe S; Leuzzi V; Cioni G; Curry CJ; Costain G; Santucci M; Chong K; Mancini GMS; Clayton-Smith J; Bigoni S; Scheffer IE; Dobyns WB; Vilsen B; Guerrini R;
    Brain; 2021 Jun; 144(5):1435-1450. PubMed ID: 33880529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications.
    Brunklaus A; Brünger T; Feng T; Fons C; Lehikoinen A; Panagiotakaki E; Vintan MA; Symonds J; Andrew J; Arzimanoglou A; Delima S; Gallois J; Hanrahan D; Lesca G; MacLeod S; Marjanovic D; McTague A; Nuñez-Enamorado N; Perez-Palma E; Scott Perry M; Pysden K; Russ-Hall SJ; Scheffer IE; Sully K; Syrbe S; Vaher U; Velayutham M; Vogt J; Weiss S; Wirrell E; Zuberi SM; Lal D; Møller RS; Mantegazza M; Cestèle S
    Brain; 2022 Nov; 145(11):3816-3831. PubMed ID: 35696452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late infantile epileptic encephalopathy: A distinct developmental and epileptic encephalopathy syndrome.
    Kacker S; Phitsanuwong C; Oetomo A; Nordli DR
    Epileptic Disord; 2024 Feb; 26(1):98-108. PubMed ID: 38100275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel ATP1A2 variant associated with severe stepwise regression, hemiplegia, epilepsy and movement disorders in two unrelated patients.
    Calame DG; Houck K; Lotze T; Emrick L; Parnes M
    Eur J Paediatr Neurol; 2021 Mar; 31():21-26. PubMed ID: 33578253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WWOX developmental and epileptic encephalopathy: Understanding the epileptology and the mortality risk.
    Oliver KL; Trivisano M; Mandelstam SA; De Dominicis A; Francis DI; Green TE; Muir AM; Chowdhary A; Hertzberg C; Goldhahn K; Metreau J; Prager C; Pinner J; Cardamone M; Myers KA; Leventer RJ; Lesca G; Bahlo M; Hildebrand MS; Mefford HC; Kaindl AM; Specchio N; Scheffer IE
    Epilepsia; 2023 May; 64(5):1351-1367. PubMed ID: 36779245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phenotypic spectrum of X-linked, infantile onset ALG13-related developmental and epileptic encephalopathy.
    Datta AN; Bahi-Buisson N; Bienvenu T; Buerki SE; Gardiner F; Cross JH; Heron B; Kaminska A; Korff CM; Lepine A; Lesca G; McTague A; Mefford HC; Mignot C; Milh M; Piton A; Pressler RM; Ruf S; Sadleir LG; de Saint Martin A; Van Gassen K; Verbeek NE; Ville D; Villeneuve N; Zacher P; Scheffer IE; Lemke JR
    Epilepsia; 2021 Feb; 62(2):325-334. PubMed ID: 33410528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical spectrum associated with ATP1A2 variants in Chinese pediatric patients.
    Dai L; Ding C; Tian X; Liu M; Ma Y; Chen C; Ren X; Li H
    Brain Dev; 2023 Sep; 45(8):422-431. PubMed ID: 37142513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Infant With Epilepsy and Recurrent Hemiplegia due to Compound Heterozygous Variants in ATP1A2.
    Wilbur C; Buerki SE; Guella I; Toyota EB; Evans DM; McKenzie MB; Datta A; Michoulas A; Adam S; Van Allen MI; Nelson TN; Farrer MJ; Connolly MB; Demos M
    Pediatr Neurol; 2017 Oct; 75():87-90. PubMed ID: 28811059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding the clinical phenotype and genetic spectrum of GEMIN5 disorders: Early-infantile developmental and epileptic encephalopathies.
    Zhang J; Liu X; Zhu G; Wan L; Liang Y; Li N; Huang M; Yang G
    Brain Behav; 2024 May; 14(5):e3535. PubMed ID: 38773790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics and gene analysis of GRIN2B gene related neurological developmental disorders in children].
    Tian XJ; Wang XH; Ding CH; Fang F; Dai LF; Deng J; Wang HM
    Zhonghua Er Ke Za Zhi; 2022 Mar; 60(3):232-236. PubMed ID: 35240744
    [No Abstract]   [Full Text] [Related]  

  • 14. Phenotypic and genetic spectrum of SCN8A-related disorders, treatment options, and outcomes.
    Gardella E; Møller RS
    Epilepsia; 2019 Dec; 60 Suppl 3():S77-S85. PubMed ID: 31904124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The phenotype and treatment of SCN2A-related developmental and epileptic encephalopathy.
    Kim HJ; Yang D; Kim SH; Kim B; Kim HD; Lee JS; Choi JR; Lee ST; Kang HC
    Epileptic Disord; 2020 Oct; 22(5):563-570. PubMed ID: 33000761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable expressivity of a likely pathogenic variant in KCNQ2 in a three-generation pedigree presenting with intellectual disability with childhood onset seizures.
    Hewson S; Puka K; Mercimek-Mahmutoglu S
    Am J Med Genet A; 2017 Aug; 173(8):2226-2230. PubMed ID: 28602030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early infantile epileptic encephalopathy caused by PACS2 gene variation: three cases report and literature review].
    Wu MJ; Hu CH; Ma JH; Hu JS; Liu ZS; Sun D
    Zhonghua Er Ke Za Zhi; 2021 Jul; 59(7):594-599. PubMed ID: 34405643
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical Benefit of NMDA Receptor Antagonists in a Patient With
    Ueda K; Serajee F; Huq AM
    Pediatrics; 2018 Apr; 141(Suppl 5):S390-S394. PubMed ID: 29610157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications.
    Johannesen KM; Liu Y; Koko M; Gjerulfsen CE; Sonnenberg L; Schubert J; Fenger CD; Eltokhi A; Rannap M; Koch NA; Lauxmann S; Krüger J; Kegele J; Canafoglia L; Franceschetti S; Mayer T; Rebstock J; Zacher P; Ruf S; Alber M; Sterbova K; Lassuthová P; Vlckova M; Lemke JR; Platzer K; Krey I; Heine C; Wieczorek D; Kroell-Seger J; Lund C; Klein KM; Au PYB; Rho JM; Ho AW; Masnada S; Veggiotti P; Giordano L; Accorsi P; Hoei-Hansen CE; Striano P; Zara F; Verhelst H; Verhoeven JS; Braakman HMH; van der Zwaag B; Harder AVE; Brilstra E; Pendziwiat M; Lebon S; Vaccarezza M; Le NM; Christensen J; Grønborg S; Scherer SW; Howe J; Fazeli W; Howell KB; Leventer R; Stutterd C; Walsh S; Gerard M; Gerard B; Matricardi S; Bonardi CM; Sartori S; Berger A; Hoffman-Zacharska D; Mastrangelo M; Darra F; Vøllo A; Motazacker MM; Lakeman P; Nizon M; Betzler C; Altuzarra C; Caume R; Roubertie A; Gélisse P; Marini C; Guerrini R; Bilan F; Tibussek D; Koch-Hogrebe M; Perry MS; Ichikawa S; Dadali E; Sharkov A; Mishina I; Abramov M; Kanivets I; Korostelev S; Kutsev S; Wain KE; Eisenhauer N; Wagner M; Savatt JM; Müller-Schlüter K; Bassan H; Borovikov A; Nassogne MC; Destrée A; Schoonjans AS; Meuwissen M; Buzatu M; Jansen A; Scalais E; Srivastava S; Tan WH; Olson HE; Loddenkemper T; Poduri A; Helbig KL; Helbig I; Fitzgerald MP; Goldberg EM; Roser T; Borggraefe I; Brünger T; May P; Lal D; Lederer D; Rubboli G; Heyne HO; Lesca G; Hedrich UBS; Benda J; Gardella E; Lerche H; Møller RS
    Brain; 2022 Sep; 145(9):2991-3009. PubMed ID: 34431999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MED13 mutation: A novel cause of developmental and epileptic encephalopathy with infantile spasms.
    Trivisano M; De Dominicis A; Micalizzi A; Ferretti A; Dentici ML; Terracciano A; Calabrese C; Vigevano F; Novelli G; Novelli A; Specchio N
    Seizure; 2022 Oct; 101():211-217. PubMed ID: 36087421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.